GENOMICA attended the last ARABHEALTH 2015 in Dubai, UAE, last 26-29 January. GENOMICA, that has achieved the total automation with the autoclart® device and is present in several screenings all [...]
The partnership will seek to improve quality cancer care in Spain by encouraging research projects, optimized use of GENOMICA diagnostic kits, scientific and medical dissemination and training of [...]
On the occasion of MEDICA, one of the world biggest trade-fairs of the healthcare sector, GENOMICA presented NEDxA, a new in vitro diagnostics device for HPV testing. The Export Sales were at the [...]
The Spanish IVD company will return to Düsseldorf to one of the most important medical congresses in the world. With more than forty years of experience, this congress gathers annually 100,000 [...]
Madrid, November 27th, 2019.- GENOMICA, the molecular diagnostics company belonging to the PharmaMar Group (MSE:PHM), begins to materialize its first contract in China with the medical equipment [...]
Last Wednesday, September 12, the Manager of the Genetic Identification Laboratory Amaya Gorostiza, participated in the talks of the week of Bioempleo that took place at the Complutense [...]
New study shows that HPV molecular testing is more effective than Pap Test for the prevention of cervical cancer. It also highlights that risk stratification by genotyping helps the doctor to [...]
On May 16th, the organization of the American Society of Clinical Oncology (ASCO) confirmed to the company the digital publication of its abstract on the comparison of its CLART® ALK · ROS1 kit [...]
Along with the recent validation of Valgent criteria and Meijer criteria, GENOMICA continues to demonstrate its value and potential in HPV full-genotyping. GENOMICA’s CLART® HPV is declared [...]
